Resmed Cdi dividend and valuation
Valuation
Resmed Cdi paid $0.25 per share in dividends over the last 12 months (yield 0.7%). Last ex-dividend date: November 11, 2026. The P/E ratio is 22.3. The average price target of 13 analysts is $43.19.
What would Resmed Cdi's dividends pay over 10 years? Work it out with the dividend calculator
Data as of November 21, 2026
Resmed Cdi compared with similar companies
Resmed Cdi's P/E (trailing 12 months): 22.3, −53% against the median of a group of 11 similar companies (47.0).
| Metric | Resmed Cdi | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| P/E (trailing 12 months) | 22.3 | 47.0 | 24.8 – 63.2 | Low |
| Forward P/E | 18.8 | 28.1 | 18.5 – 37.6 | Middle |
| EV/EBITDA | 9.45 | 18.9 | 16.3 – 28.6 | Low |
| Price/book | 2.36 | 5.57 | 2.64 – 8.37 | Low |
| Price/sales | 8.70 | 7.27 | 4.40 – 8.35 | High |
| Gross margin | 61.8% | 57.9% | 43.0% – 62.7% | Middle |
| Operating margin | 34.0% | 22.9% | 14.0% – 30.8% | High |
| Net margin | 27.8% | 14.0% | 8.6% – 24.0% | High |
| ROE | 26.4% | 17.0% | 8.9% – 24.9% | High |
| Debt/equity | 0.10 | 0.21 | 0.10 – 0.37 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Other metrics
Valuation multiples
- Market cap
- $49.85B
- Enterprise value
- $20.09B
- PEG
- 1.31
- EV/revenue
- 3.50
Profitability and growth
- ROA
- 14.8%
- ROIC
- 18.0%
- Revenue growth (year over year)
- 5.9%
- Earnings growth (year over year)
- 23.2%
Financial health
- Total cash
- $1.01B
- Total debt
- $610.58M
- Current ratio
- 2.65
- Quick ratio
- 1.54
Dividends
- Annual dividend per share
- $0.25
- Dividend yield
- 0.7%
- Payout ratio
- 15.9%
- Ex-dividend date
- November 11, 2026
Analysts and estimates
- Average price target
- $43.19
- Median price target
- $42.22
- High price target
- $49.02
- Low price target
- $37.69
- Analysts with a price target
- 13
- Consensus
- Buy
- Forward EPS
- $1.89
- EPS estimate, current year
- $1.21
Shares and trading
- Beta
- 0.76
- Average volume
- 1.48M
- Shares outstanding
- 1.41B
- Float
- 559.2M
- Institutional ownership
- 10.1%
- Insider ownership
- 0.0%
